Drawing for IVERA

USPTO serial 99678202

IVERA

Status 686
Filing date
Mar 2, 2026
Status date
Aug 11, 2026
Registration date
Examiner
SHIH, SALLY

Need help with IVERA?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Owner

  • US Health Express Corp

    La Puente, CA, US

  • US Health Express Corp

    La Puente, CA, US

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic reagents for medical use in in vitro diagnosis; In vitro diagnostic preparations for medical purposes; In vitro diagnostic preparations for medical use; Diagnostic biomarkers for in vitro testing for medical use; Medical diagnostic reagents for use in detecting drug use; Medical diagnostic reagents for use in drug screening and test; Diagnostic reagents for medical purposes for use in covid and flu; Medical diagnostic reagents for use in cancer; Medical diagnostic reagents for use in pregnancy; Medical diagnostic reagents for use in STD; Medical diagnostic reagents for use in common infectious diseasesACTIVE

Prosecution history

DateCodeEvent
Aug 11, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 11, 2026PUBOPUBLISHED FOR OPPOSITION
Aug 5, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 16, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 24, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 24, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 16, 2026GNRTNON-FINAL ACTION E-MAILED
Jun 16, 2026CNRTNON-FINAL ACTION WRITTEN
Jun 16, 2026DOCKASSIGNED TO EXAMINER
Mar 2, 2026MAFRAPPLICATION FILING RECEIPT MAILED
Mar 2, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 2, 2026NWAPNEW APPLICATION ENTERED

Related guidance